High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

Medicine and Dentistry

• Adverse Event 10%
• Analysis 10%
• Carbonate Dehydratase IX 10%
• Clear Cell 10%
• Comprehension 10%
• Death 10%
• Disease Burden 10%
• Disease Free Survival 10%
• Drug Megadose 10%
• Evaluation Study 10%
• Examination 10%
• Experience 20%
• Follow up 10%
• Growth 10%
• Histology 10%
• Immunotherapy 10%
• Kidney Metastasis 10%
• Morphology 10%
• Multivariate Analysis 10%
• Neoplasm 10%
• Organ 10%
• Pathology 40%
• Patient 80%
• Predictive Factor 10%
• Predictor 10%
• Prognostic Factor 10%
• Relapse 10%
• Sarcomatoid 10%
• Specimen 10%
• Spontaneous Remission 20%
• Surgery 10%
• Survival 10%
• Survival Rate 10%
• Targeted Therapy 10%
• Therapeutic Procedure 100%
• Toxicity 10%